Mason Michael
CIK 0001514291 Name as filed on the most recent filing
Filed as Mason Michael (27)
53 transaction lines · from 27 filings · filed 2012-07-18 to 2024-09-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
53 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2024-09-04 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 7,050 disposed | 0.72 | 5,088.69 | Form 4, filing 0000950170-24-104031 | |
| 2024-06-04 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 652 disposed | 0.99 | 645.48 | Form 4, filing 0000950170-24-069860 | |
| 2024-03-01 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 6,162 disposed | 1.20 | 7,394.40 | Form 4, filing 0000950170-24-025191 | |
| 2024-02-29 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 27,687 disposed | 1.17 | 32,393.79 | Form 4, filing 0000950170-24-025191 | |
| 2024-02-27 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 2,545 disposed | 1.32 | 3,369.07 | Form 4, filing 0000950170-24-023292 | |
| 2024-02-06 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 4,205 disposed | 1.59 | 6,671.23 | Form 4, filing 0000950170-24-012832 | |
| 2023-09-01 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 6,913 disposed | 1.33 | 9,203.28 | Form 4, filing 0001209191-23-048162 | |
| 2023-06-02 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 631 disposed | 2.22 | 1,400.82 | Form 4, filing 0001209191-23-034262 | |
| 2023-03-01 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 11,205 disposed | 3.03 | 33,942.19 | Form 4, filing 0001209191-23-014843 | |
| 2023-02-27 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 2,802 disposed | 3.04 | 8,509.11 | Form 4, filing 0001209191-23-014078 | |
| 2023-02-06 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 4,141 disposed | 3.40 | 14,079.40 | Form 4, filing 0001209191-23-007775 | |
| 2022-06-03 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 598 disposed | 6.04 | 3,611.92 | Form 4, filing 0000899243-22-021234 | |
| 2022-06-03 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 3 disposed | 6.07 | 18.20 | Form 4, filing 0000899243-22-021234 | |
| 2022-02-28 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 2,398 disposed | 10.24 | 24,549.52 | Form 4, filing 0001209191-22-014628 | |
| 2022-02-07 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 3,947 disposed | 9.86 | 38,925.31 | Form 4, filing 0001209191-22-008126 | |
| 2021-02-11 |
Karyopharm Therapeutics Inc. KPTI |
S, Open-market sale | 2,858 disposed | 15.52 | 44,353.59 | Form 4, filing 0001209191-21-011488 | |
| 2018-01-04 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 16,500 disposed | 131.20 | 2,164,800.00 | Form 4, filing 0001325812-18-000004 | |
| 2018-01-04 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 12,405 disposed | 132.18 | 1,639,692.90 | Form 4, filing 0001325812-18-000004 | |
| 2018-01-04 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 5,249 disposed | 130.42 | 684,574.58 | Form 4, filing 0001325812-18-000004 | |
| 2018-01-04 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,591 disposed | 132.98 | 211,571.18 | Form 4, filing 0001325812-18-000004 | |
| 2018-01-04 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 600 disposed | 135.00 | 81,000.00 | Form 4, filing 0001325812-18-000004 | |
| 2018-01-04 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 400 disposed | 133.83 | 53,532.00 | Form 4, filing 0001325812-18-000004 | |
| 2017-05-16 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 9,375 disposed | 70.00 | 656,250.00 | Form 4, filing 0001553878-17-000013 | |
| 2015-06-01 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 2,064 disposed | 132.49 | 273,451.52 | Form 4, filing 0001553878-15-000026 | |
| 2015-06-01 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,767 disposed | 131.56 | 232,472.88 | Form 4, filing 0001553878-15-000026 | |
| 2015-06-01 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 760 disposed | 130.39 | 99,098.00 | Form 4, filing 0001553878-15-000026 | |
| 2015-06-01 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 200 disposed | 133.12 | 26,624.00 | Form 4, filing 0001553878-15-000026 | |
| 2014-12-15 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 8,704 disposed | 95.10 | 827,746.92 | Form 4, filing 0001553878-14-000031 | |
| 2014-12-15 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 4,128 disposed | 95.97 | 396,153.43 | Form 4, filing 0001553878-14-000031 | |
| 2014-12-15 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 2,000 disposed | 101.75 | 203,494.00 | Form 4, filing 0001553878-14-000031 | |
| 2014-12-15 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,835 disposed | 100.52 | 184,447.04 | Form 4, filing 0001553878-14-000031 | |
| 2014-12-15 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,475 disposed | 99.73 | 147,108.98 | Form 4, filing 0001553878-14-000031 | |
| 2014-12-15 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,400 disposed | 97.12 | 135,965.06 | Form 4, filing 0001553878-14-000031 | |
| 2014-12-15 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 900 disposed | 102.56 | 92,305.98 | Form 4, filing 0001553878-14-000031 | |
| 2014-12-15 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 900 disposed | 98.48 | 88,634.97 | Form 4, filing 0001553878-14-000031 | |
| 2014-12-15 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 820 disposed | 103.60 | 84,952.08 | Form 4, filing 0001553878-14-000031 | |
| 2014-02-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 2,110 disposed | 79.04 | 166,769.12 | Form 4, filing 0001325812-14-000022 | |
| 2014-02-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,540 disposed | 78.08 | 120,249.36 | Form 4, filing 0001325812-14-000022 | |
| 2014-02-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 100 disposed | 79.74 | 7,974.00 | Form 4, filing 0001325812-14-000022 | |
| 2013-12-16 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 5,800 disposed | 60.20 | 349,181.46 | Form 4, filing 0001325812-13-000013 | |
| 2013-12-16 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 2,200 disposed | 60.77 | 133,690.92 | Form 4, filing 0001325812-13-000013 | |
| 2013-12-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,905 disposed | 61.55 | 117,257.13 | Form 4, filing 0001325812-13-000008 | |
| 2013-12-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,845 disposed | 62.12 | 114,605.50 | Form 4, filing 0001325812-13-000008 | |
| 2013-07-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 14,200 disposed | 50.00 | 710,000.00 | Form 4, filing 0001553878-13-000023 | |
| 2013-07-01 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 15,000 disposed | 32.00 | 480,000.00 | Form 4, filing 0001553878-13-000021 | |
| 2013-07-01 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 12,000 disposed | 32.00 | 384,000.00 | Form 4, filing 0001553878-13-000021 | |
| 2013-06-17 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 13,000 disposed | 29.93 | 389,125.10 | Form 4, filing 0001553878-13-000020 | |
| 2013-06-17 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 6,250 disposed | 29.93 | 187,079.38 | Form 4, filing 0001553878-13-000020 | |
| 2013-06-17 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 4,375 disposed | 29.93 | 130,955.56 | Form 4, filing 0001553878-13-000020 | |
| 2012-11-30 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 3,750 disposed | 16.93 | 63,472.12 | Form 4, filing 0001553878-12-000005 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 53
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Mason Michael, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001514291
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6